Healthcare provider profile · identity verified

Serah W. Muhoro

Nurse Practitioner · WILMINGTON, DE · NPI 1184134801

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	618	64
Amlodipine Besylate	Amlodipine Besylate	408	39
Gabapentin	Gabapentin	311	39
Lisinopril	Lisinopril	258	29
Omeprazole	Omeprazole	229	28
Metformin Hcl	Metformin Hcl	218	21
Potassium Chloride	Potassium Chloride	170	20
Furosemide	Furosemide	163	31
Eliquis	Apixaban	161	16
Duloxetine Hcl	Duloxetine Hcl	149	12
Glipizide	Glipizide	145	suppressed
Metoprolol Succinate	Metoprolol Succinate	143	21
Levothyroxine Sodium	Levothyroxine Sodium	142	15
Pravastatin Sodium	Pravastatin Sodium	139	11
Trazodone Hcl	Trazodone Hcl	123	15
Jardiance	Empagliflozin	112	15
Metoprolol Tartrate	Metoprolol Tartrate	111	12
Sertraline Hcl	Sertraline Hcl	108	18
Xarelto	Rivaroxaban	100	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	97	11
Bupropion Xl	Bupropion Hcl	93	suppressed
Mirtazapine	Mirtazapine	89	suppressed
Simvastatin	Simvastatin	84	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	76	11
Hydrochlorothiazide	Hydrochlorothiazide	74	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	74	suppressed
Carvedilol	Carvedilol	73	suppressed
Allopurinol	Allopurinol	71	suppressed
Baclofen	Baclofen	70	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	67	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	64	suppressed
Fluticasone Propionate	Fluticasone Propionate	62	16
Metformin Hcl Er	Metformin Hcl	62	11
Montelukast Sodium	Montelukast Sodium	59	suppressed
Latanoprost	Latanoprost	53	suppressed
Buspirone Hcl	Buspirone Hcl	50	suppressed
Memantine Hcl	Memantine Hcl	50	suppressed
Losartan Potassium	Losartan Potassium	49	suppressed
Ezetimibe	Ezetimibe	47	suppressed
Ozempic	Semaglutide	46	suppressed
Januvia	Sitagliptin Phosphate	45	suppressed
Spironolactone	Spironolactone	45	suppressed
Tramadol Hcl	Tramadol Hcl	45	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	44	suppressed
Bumetanide	Bumetanide	43	suppressed
Lamotrigine	Lamotrigine	43	suppressed
Prednisone	Prednisone	43	17
Pregabalin	Pregabalin	43	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	41	suppressed
Entresto	Sacubitril/Valsartan	40	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	40	suppressed
Ibuprofen	Ibuprofen	40	19
Famotidine	Famotidine	39	suppressed
Myrbetriq	Mirabegron	39	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	37	suppressed
Atenolol	Atenolol	35	suppressed
Methenamine Hippurate	Methenamine Hippurate	35	suppressed
Chlorthalidone	Chlorthalidone	34	suppressed
Clopidogrel	Clopidogrel Bisulfate	34	suppressed
Valacyclovir	Valacyclovir Hcl	34	suppressed
Amiodarone Hcl	Amiodarone Hcl	32	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Raloxifene Hcl	Raloxifene Hcl	31	suppressed
Meclizine Hcl	Meclizine Hcl	30	suppressed
Amantadine	Amantadine Hcl	29	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	29	suppressed
Naproxen	Naproxen	29	suppressed
Phenytoin	Phenytoin	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Enalapril Maleate	Enalapril Maleate	27	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Divalproex Sodium	Divalproex Sodium	25	suppressed
Celecoxib	Celecoxib	24	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	23	19
Donepezil Hcl	Donepezil Hcl	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	22	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Folic Acid	Folic Acid	22	suppressed
Nystop	Nystatin	22	suppressed
Insulin Aspart Flexpen	Insulin Aspart	21	suppressed
Prazosin Hcl	Prazosin Hcl	21	suppressed
Torsemide	Torsemide	21	suppressed
Loperamide	Loperamide Hcl	20	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Glipizide Er	Glipizide	19	suppressed
Trexall	Methotrexate Sodium	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Lactulose	Lactulose	17	suppressed
Loteprednol Etabonate	Loteprednol Etabonate	17	suppressed
Meloxicam	Meloxicam	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Topiramate	Topiramate	17	suppressed
Xiidra	Lifitegrast	17	suppressed
Finasteride	Finasteride	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Cephalexin	Cephalexin	15	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	15	suppressed
Mirabegron Er	Mirabegron	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	11
Valproic Acid	Valproic Acid (As Sodium Salt)	15	suppressed
Clonidine	Clonidine	14	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	14	suppressed
Invokana	Canagliflozin	14	suppressed
Leflunomide	Leflunomide	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Prednisolone Acetate	Prednisolone Acetate	14	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Triumeq	Abacavir/Dolutegravir/Lamivudi	13	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Methimazole	Methimazole	12	suppressed
Odefsey	Emtricitab/Rilpiviri/Tenof Ala	12	suppressed
Serevent Diskus	Salmeterol Xinafoate	12	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	12	11
Symtuza	Darunavir/Cob/Emtri/Tenof Alaf	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Cequa	Cyclosporine	11	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Gemtesa	Vibegron	11	suppressed
Ondansetron Odt	Ondansetron	11	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error